Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000666811 | SCV000791167 | uncertain significance | Wilson disease | 2017-05-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000666811 | SCV000894840 | uncertain significance | Wilson disease | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000666811 | SCV002027166 | uncertain significance | Wilson disease | 2021-09-05 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003987656 | SCV004804498 | uncertain significance | not specified | 2024-01-12 | criteria provided, single submitter | clinical testing | Variant summary: ATP7B c.2480G>T (p.Arg827Leu) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 249562 control chromosomes. c.2480G>T has been reported in the literature in at least two individuals affected with Wilson Disease in the compond heterozygous state (Ferenci_2014, Ferenci_2019). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. ClinVar contains an entry for this variant (Variation ID: 551685). Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. |